Shares of ResMed Inc. shed 8.33% to $236.18 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.50% to 6,040.53 and Dow Jones ...

Revenue surged 11% year over year to $1.2 billion, driven by strength across sleep devices and software segments. Gross margin improved significantly by 420 basis points, hitting 58.6%. Operating ...

With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD) is a global leader in designing, manufacturing, and distributing medical devices and cloud-based software ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the second quarter of fiscal 2025 were $2.43, up 29.2% year over year. The metric beat the Zacks Consensus Estimate by 5.6%. The adjustments ...